Strs Ohio Cara Therapeutics, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$7.45 - $13.84 $363,560 - $675,392	-48,800 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$9.94 - $12.65 $169,974 - $216,315	-17,100 Reduced 25.95%	48,800 $592,000
Q4 2021 Jan 24, 2022	BUY	$11.99 - $18.14 $113,905 - $172,330	9,500 Added 16.84%	65,900 $802,000
Q3 2021 Oct 22, 2021	SELL	$11.55 - $16.06 $48,510 - $67,452	-4,200 Reduced 6.93%	56,400 $871,000
Q2 2021 Jul 26, 2021	BUY	$12.38 - $29.19 $722,992 - $1.7 Million	58,400 Added 2654.55%	60,600 $864,000
Q1 2021 Apr 23, 2021	BUY	$15.07 - $21.71 $33,154 - $47,762	2,200 New	2,200 $47,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.